Results 171 to 180 of about 35,603 (238)

New prognostic and predictive scoring systems for colorectal cancer liver metastases. [PDF]

ESMO Open
Salvà F, Pérez Fernandez S, Dopazo C, Salcedo M, Saoudi N, Rodriguez M, Baraibar I, Ros J, Salva de Torres C, Vaghi C, Calixto Z, Gómez-Gavara C, Caralt M, Sapisochin G, Tabernero J, Elez E.   +15 more
europepmc   +1 more source

Mapping coastal transformations with a novel Cellular Automata-Markov-Random forest framework for land use change modeling. [PDF]

Sci Rep
Nikoo MR, Zarei E, Al-Wardy M.
europepmc   +1 more source

A New Grateloupia (Red Alga) from Hawaii [PDF]

, 1958
Dawson, E. Yale
core  

Navigating the Colorectal Cancer Maze: Unveiling Pathways To Diagnosis, Management, Pathophysiology and Prevention. [PDF]

Curr Oncol Rep
Al Kamzari KAM, Constantinou C.
europepmc   +1 more source

Forest Therapy Trails: Development and Application of an Assessment Protocol. [PDF]

Int J Environ Res Public Health
Gobster PH.
europepmc   +1 more source

Persistent species relationships characterize migrating bird communities across stopover sites and seasons. [PDF]

Proc Natl Acad Sci U S A
DeSimone JG, DeGroote LW, MacKenzie SA, Owen JC, Patterson AJ, Cohen EB.   +5 more
europepmc   +1 more source

Durable response to third-line combination therapy in a metastatic colorectal cancer patient with BRAF V600E mutation: A case report. [PDF]

Hum Vaccin Immunother
Zhang Q, Li L, Qian X.
europepmc   +1 more source

Preventing Fishing Gear Loss from Vessel Interactions in New England [PDF]

, 2017
Jedziniak, Jamison, Rhode Island Sea Grant Law Fellow Program, Marine Affairs Institute (MAI), Roger Williams University School of Law   +1 more
core   +1 more source

Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer. [PDF]

Explor Target Antitumor Ther
Rojas M, Manzi M, Madurga S, García Velásquez FE, Romero MA, Marín S, Cascante M, Maurel J.   +7 more
europepmc   +1 more source

Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer. [PDF]

NPJ Precis Oncol
Sahin IH, Xiu J, Baca Y, Khushman M, Grothey A, Palumbo E, Rahman S, Weinberg BA, Goel S, Akce M, Gorantla V, Lou E, Kasi A, Shields AF, Oberley M, Sledge G, Shen JP, Saeed A, Tejani M.   +18 more
europepmc   +1 more source